The hormone resistin links obesity to diabetes
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is a chronic disease that leads to complications including heart disease, stroke, kidney failure, blindness and nerve damage. Type 2 diabetes, characterized by target-tissue resistance to insulin, is epidemic in industrialized societies and is strongly associated with obesity; however, the mechanism by which increased adiposity causes insulin resistance is unclear. Here we show that adipocytes secrete a unique signalling molecule, which we have named resistin (for resistance to insulin). Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Administration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity. Moreover, treatment of normal mice with recombinant resistin impairs glucose tolerance and insulin action. Insulin-stimulated glucose uptake by adipocytes is enhanced by neutralization of resistin and is reduced by resistin treatment. Resistin is thus a hormone that potentially links obesity to diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, resistin is predominantly secreted by adipose tissue, whereas in humans, it is primarily produced by immune cells, suggesting a potential species-specific functional divergence [9].”
From The Resistin/TLR4/miR-155-5p axis: a novel signaling pathway in the onset of hypothalamic neuroinflammation (2025) · cites this paper as [9]
In the citing paper
“The subcutaneous injection of estradiol benzoate reduces resistin levels in adipocytes [136].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [136]
Citations
Cites
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
Nielsen, H., Engelbrecht, J., Brunak, S., & von Heijne, G. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.1 · Cited by 5,356
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationNakai, K., & Horton, P. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01336-x · Cited by 2,181 · cited 1×
“A notable feature of the deduced amino-acid sequence of resistin is a hydrophobic amino terminus that is predicted by the Prosor”
BackgroundmPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Cited by
Items 301–400 of 1,052
Presle, N., Pottie, P., Dumond, H., Guillaume, C., Lapicque, F., Pallu, S., Mainard, D., Netter, P., & Terlain, B. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.01.009 · Cited by 291
Greenberg, A. S., & McDaniel, M. L. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.4.x · Cited by 290
Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Tao, H., Zhang, Y., Zeng, X., Shulman, G. I., & Jin, S. (2014) · Nature Medicine · doi:10.1038/nm.3699 · Cited by 288
Do regional differences in adipocyte biology provide new pathophysiological insights?
Lafontan, M., & Berlan, M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00132-9 · Cited by 288
The impact of ethnicity on type 2 diabetes
Abate, N., & Chandalia, M. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00190-3 · Cited by 284
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
Cytokines and abnormal glucose and lipid metabolism
Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282
“In mice, resistin is synthesized mainly in adipocytes (16), whereas in humans, resistin is predominantly produced by macrophages infiltrating adipose tissue and peripheral blood mononuclear cells, and it is not detectable in adipocytes (165).”
BackgroundRodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., & Frühbeck, G. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2015 · Cited by 282
Adipogenesis: cellular and molecular aspects
Fève, B. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.007 · Cited by 281
Activation of SOCS-3 by Resistin
Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J., & Lazar, M. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1569-1575.2005 · Cited by 281
Self-citationStraczkowski, M., Dzienis-Straczkowska, S., Stêpieñ, A., Kowalska, I., Szelachowska, M., & Kinalska, I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020135 · Cited by 280
Role of resistin in obesity, insulin resistance and Type II diabetes
Kusminski, C. M., Mcternan, P. G., & Kumar, S. (2005) · Clinical Science · doi:10.1042/cs20050078 · Cited by 280
Lee, S., Lee, H.-C., Kwon, Y.-W., Lee, S. E., Cho, Y., Kim, J., Lee, S., Kim, J.-Y., Lee, J., Yang, H.-M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.013 · Cited by 280
Self-citationMcTernan, P. G., Fisher, F. M., Valsamakis, G., Chetty, R., Harte, A., McTernan, C. L., Clark, P. M. S., Smith, S. A., Barnett, A. H., & Kumar, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030898 · Cited by 280
Inter-organ cross-talk in metabolic syndrome
Priest, C., & Tontonoz, P. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0145-5 · Cited by 279
Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity
Zhang, J., Fu, M., Cui, T., Xiong, C., Xu, K., Zhong, W., Xiao, Y., Floyd, D., Liang, J., Li, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403652101 · Cited by 279
The Potential of Adiponectin in Driving Arthritis
Ehling, A., Schäffler, A., Herfarth, H., Tarner, I. H., Anders, S., Distler, O., Paul, G., Distler, J., Gay, S., Schölmerich, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4468 · Cited by 278
Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence
Diamant, M., & Heine, R. J. (2003) · Drugs · doi:10.2165/00003495-200363130-00004 · Cited by 277
Leal, V. D. O., & Mafra, D. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.003 · Cited by 277
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues
LeBrasseur, N. K., Kelly, M., Tsao, T.-S., Farmer, S. R., Saha, A. K., Ruderman, N. B., & Tomas, E. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00453.2005 · Cited by 276
“Through PPAR , TZDs modulate the transcription of essential genes involved in preadipocyte differentiation (15, 16), fatty acid transport (12, 30), synthesis, and storage (7, 41), and the synthesis of fat-derived signaling molecules including leptin (10, 19), TNF(31, 34), resistin (40, 44), and adiponectin (27).”
BackgroundObesity, Inflammation and Diet
Lee, H., Lee, I. S., & Choue, R. (2013) · Pediatric Gastroenterology, Hepatology & Nutrition · doi:10.5223/pghn.2013.16.3.143 · Cited by 275
Miyazaki, Y., Glass, L., Triplitt, C., Matsuda, M., Cusi, K., Mahankali, A., Mahankali, S., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetologia · doi:10.1007/s001250100031 · Cited by 274
The adipocyte as an endocrine organ in the regulation of metabolic homeostasis
Harwood, H. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.010 · Cited by 273
Kadowaki, T., Yamauchi, T., & Kubota, N. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.070 · Cited by 272
Dyck, D. J., Heigenhauser, G. J. F., & Bruce, C. R. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2005.01502.x · Cited by 272
Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B. J., Withers, S. B., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 272
Franssen, R., Monajemi, H., Stroes, E. S. G., & Kastelein, J. J. P. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.003 · Cited by 270
PPARadigms and PPARadoxes: expanding roles for PPARγ in the control of lipid metabolism
Walczak, R., & Tontonoz, P. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30159-0 · Cited by 270
Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats
Satoh, H., Nguyen, M. T., Miles, P. D. G., Imamura, T., Usui, I., & Olefsky, J. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420785 · Cited by 268
Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1
Chen, H. C., Smith, S. J., Ladha, Z., Jensen, D. R., Ferreira, L. D., Pulawa, L. K., McGuire, J. G., Pitas, R. E., Eckel, R. H., & Farese, R. V. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214672 · Cited by 266
Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum
Šenolt, L., Housa, D., Vernerová, Z., Jirásek, T., Svobodová, R., Veigl, D., Anderlová, K., Müller-Ladner, U., Pavelka, K., & Haluzík, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054734 · Cited by 265
Energy Homeostasis, Obesity and Eating Disorders: Recent Advances in Endocrinology
Gale, S. M., Castracane, V. D., & Mantzoros, C. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.2.295 · Cited by 265
Lee, K., Villena, J. A., Moon, Y. S., Kim, K.-H., Lee, S., Kang, C., & Sul, H. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15924 · Cited by 264
Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin
Piya, M. K., McTernan, P. G., & Kumar, S. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0498 · Cited by 264
Johnson, P. J. (2002) · Veterinary Clinics of North America: Equine Practice · doi:10.1016/s0749-0739(02)00006-8 · Cited by 264
Mesenteric fat in Crohn’s disease: a pathogenetic hallmark or an innocent bystander?
Peyrin-Biroulet, L., Chamaillard, M., Gonzalez, F., Beclin, E., Decourcelle, C., Antunes, L., Gay, J., Neut, C., Colombel, J.-F., & Desreumaux, P. (2007) · Gut · doi:10.1136/gut.2005.082925 · Cited by 264
Resistin, Obesity, and Insulin Resistance — The Emerging Role of the Adipocyte as an Endocrine Organ
Shuldiner, A. R., Yang, R., & Gong, D.-W. (2001) · New England Journal of Medicine · doi:10.1056/nejm200111013451814 · Cited by 264
Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-α with Insulin Resistance
Hivert, M.-F., Sullivan, L. M., Fox, C. S., Nathan, D. M., D’Agostino, R. B., Wilson, P. W. F., & Meigs, J. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0425 · Cited by 262
Fat as an Endocrine Organ: Relationship to the Metabolic Syndrome
Hutley, L., & Prins, J. B. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00005 · Cited by 262
Jadoon, K. A., Ratcliffe, S. H., Barrett, D. A., Thomas, E. L., Stott, C., Bell, J. D., O’Sullivan, S. E., & Tan, G. D. (2016) · Diabetes Care · doi:10.2337/dc16-0650 · Cited by 262
Recinella, L., Orlando, G., Ferrante, C., Chiavaroli, A., Brunetti, L., & Leone, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.578966 · Cited by 261
Subcutaneous fat in normal and diseased states
Avram, M. M., Avram, A. S., & James, W. D. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.022 · Cited by 261
Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M., & Paschke, R. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02960-x · Cited by 261
Resistin is secreted from macrophages in atheromas and promotes atherosclerosis
JUNG, H., PARK, K., CHO, Y., CHUNG, S., CHO, H., CHO, S., KIM, S., KIM, S., LEE, H., & PARK, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.09.015 · Cited by 261
Nguyen, V. D., Hatahet, F., Salo, K. E., Enlund, E., Zhang, C., & Ruddock, L. W. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-1 · Cited by 260
“Resistin is a hormone linked to the suppression of glucose uptake into adipose cells by insulin [21].”
BackgroundAdipokines: implications for female fertility and obesity
Mitchell, M., Armstrong, D. T., Robker, R. L., & Norman, R. J. (2005) · Reproduction · doi:10.1530/rep.1.00521 · Cited by 259
The release of the adipocytokine visfatin is regulated by glucose and insulin
Haider, D. G., Schaller, G., Kapiotis, S., Maier, C., Luger, A., & Wolzt, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0303-7 · Cited by 258
“The adipose tissue acts as an endocrine organ and produces several hormones, including leptin [1], adiponectin [2–4], resistin [5] and the recently described visfatin/ pre-B cell colony-enhancing factor [6].”
BackgroundDepression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity
Stuart, M. J., & Baune, B. T. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.001 · Cited by 257
C1q/TNF-related Protein-3 (CTRP3), a Novel Adipokine That Regulates Hepatic Glucose Output
Peterson, J. M., Wei, Z., & Wong, G. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180695 · Cited by 257
The adipocyte as an active participant in energy balance and metabolism
Badman, M. K., & Flier, J. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.058 · Cited by 256
New markers of insulin resistance in polycystic ovary syndrome
Polak, K., Czyzyk, A., Simoncini, T., & Meczekalski, B. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0523-8 · Cited by 256
The role of intramuscular lipid in insulin resistance
Hegarty, B. D., Furler, S. M., Ye, J., Cooney, G. J., & Kraegen, E. W. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01162.x · Cited by 256
Knouff, C., & Auwerx, J. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0036 · Cited by 256
Non-invasive means of measuring hepatic fat content
Mehta, S. R., Thomas, E. L., Bell, J. D., Johnston, D. G., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3476 · Cited by 255
Resistin, Adiponectin, and Risk of Heart Failure
Frankel, D. S., Vasan, R. S., D'Agostino, R. B., Benjamin, E. J., Levy, D., Wang, T. J., & Meigs, J. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.073 · Cited by 255
Resistin release by human adipose tissue explants in primary culture
Fain, J. N., Cheema, P. S., Bahouth, S. W., & Lloyd Hiler, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02864-4 · Cited by 254
Baratta, R., Amato, S., Degano, C., Farina, M. G., Patanè, G., Vigneri, R., & Frittitta, L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031777 · Cited by 252
Hyperglycemia and antipsychotic medications.
Haupt, D. W., & Newcomer, J. W. (2001) · PubMed · Cited by 252
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus
Miyazaki, Y., Glass, L., Triplitt, C., Wajcberg, E., Mandarino, L. J., & DeFronzo, R. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.0327.2001 · Cited by 251
Cytosolic NADP+-dependent Isocitrate Dehydrogenase Plays a Key Role in Lipid Metabolism
Koh, H.-J., Lee, S.-M., Son, B.-G., Lee, S.-H., Ryoo, Z. Y., Chang, K.-T., Park, J.-W., Park, D.-C., Song, B. J., Veech, R. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402260200 · Cited by 251
The potential role of resistin in atherogenesis
Burnett, M. S., Lee, C. W., Kinnaird, T. D., Stabile, E., Durrani, S., Dullum, M. K., Devaney, J. M., Fishman, C., Stamou, S., Canos, D., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.014 · Cited by 250
Kratchmarova, I., Kalume, D. E., Blagoev, B., Scherer, P. E., Podtelejnikov, A. V., Molina, H., Bickel, P. E., Andersen, J. S., Fernandez, M. M., Bunkenborg, J., et al. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200006-mcp200 · Cited by 249
Axelsson, J., Bergsten, A., Qureshi, A. R., Heimbürger, O., Bárány, P., Lönnqvist, F., Lindholm, B., Nordfors, L., Alvestrand, A., & Stenvinkel, P. (2006) · Kidney International · doi:10.1038/sj.ki.5000089 · Cited by 249
Ross, S. E., Erickson, R. L., Gerin, I., DeRose, P. M., Bajnok, L., Longo, K. A., Misek, D. E., Kuick, R., Hanash, S. M., Atkins, K. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5989-5999.2002 · Cited by 248
Psoriasis patients show signs of insulin resistance
Boehncke, S., Thaci, D., Beschmann, H., Ludwig, R. J., Ackermann, H., Badenhoop, K., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08190.x · Cited by 248
Moloney, F., Yeow, T.-P., Mullen, A., Nolan, J. J., & Roche, H. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.887 · Cited by 247
Adipocyte-Derived Hormones, Cytokines, and Mediators
Rondinone, C. M. (2006) · Endocrine · doi:10.1385/endo:29:1:81 · Cited by 247
Adiponectin and its role in the obesity-induced insulin resistance and related complications.
Haluzík, M., Pařízková, J., & Haluzík, M. (2004) · Physiological Research · doi:10.33549/physiolres.930479 · Cited by 247
Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H. R., & Gao, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873699 · Cited by 244
Lappas, M., Yee, K., Permezel, M., & Rice, G. E. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06227 · Cited by 244
Adiponectin: Systemic contributor to insulin sensitivity
Pajvani, U. B., & Scherer, P. E. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0065-2 · Cited by 244
Sopasakis, V. R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., Jansson, P., & Smith, U. (2004) · Obesity Research · doi:10.1038/oby.2004.51 · Cited by 243
Expression and Regulation of Adiponectin and Receptor in Human and Rat Placenta
Caminos, J. E., Nogueiras, R., Gallego, R., Bravo, S., Tovar, S., García-Caballero, T., Casanueva, F. F., & Diéguez, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0930 · Cited by 242
PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance
Guerre-Millo, M., Rouault, C., Poulain, P., André, J., Poitout, V., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Reach, G., & Staels, B. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2809 · Cited by 241
Cross‐Talk between PPAR γ and Insulin Signaling and Modulation of Insulin Sensitivity
Leonardini, A., Laviola, L., Perrini, S., Natalicchio, A., & Giorgino, F. (2009) · PPAR Research · doi:10.1155/2009/818945 · Cited by 241
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
Adolph, T., Grander, C., Grabherr, F., & Tilg, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081649 · Cited by 240
Hepatitis C virus infection: Molecular pathways to metabolic syndrome
Sheikh, M. Y., Choi, J., Qadri, I., Friedman, J. E., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22269 · Cited by 240
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239
“In contrast, adipose mRNA-encoding resistin, which may lead to insulin resistance (Steppan et al., 2001), is reduced in transgenic adipose tissue, perhaps as a consequence of glucocorticoid excess (Viengchareun et al., 2002).”
Carvalho, E., Kotani, K., Peroni, O. D., & Kahn, B. B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2005 · Cited by 238
Tataranni, P. A., & Ortega, E. (2005) · Diabetes · doi:10.2337/diabetes.54.4.917 · Cited by 238
Inflammation and metabolic dysfunction: links to cardiovascular diseases
Taube, A., Schlich, R., Sell, H., Eckardt, K., & Eckel, J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00907.2011 · Cited by 238
Kremen, J., Dolinkova, M., Krajickova, J., Blaha, J., Anderlova, K., Lacinova, Z., Haluzikova, D., Bosanska, L., Vokurka, M., Svacina, S., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1044 · Cited by 238
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
Defronzo, R. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00389.x · Cited by 236
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre‐eclampsia
Miehle, K., Stepan, H., & Fasshauer, M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04234.x · Cited by 236
LeRoith, D. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01276-7 · Cited by 236
Pomegranate and type 2 diabetes
Banihani, S., Swedan, S., & Alguraan, Z. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.03.003 · Cited by 236
Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
Katagiri, H., Yamada, T., & Oka, Y. (2007) · Circulation Research · doi:10.1161/circresaha.107.151621 · Cited by 235
Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation
Johnston, A., Arnadottir, S., Gudjonsson, J. E., Aphale, A., Sigmarsdottir, A. A., Gunnarsson, S. I., Steinsson, J. T., Elder, J. T., & Valdimarsson, H. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08655.x · Cited by 235
Groop, L., & Orho‐Melander, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00864.x · Cited by 234
The autocrine and paracrine roles of adipokines
Karastergiou, K., & Mohamed-Ali, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.11.011 · Cited by 233
Koliwad, S. K., Streeper, R. S., Monetti, M., Cornelissen, I., Chan, L., Terayama, K., Naylor, S., Rao, M., Hubbard, B., & Farese, R. V. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36066 · Cited by 233
Adipokines, inflammation, and the endothelium in diabetes
Aldhahi, W., & Hamdy, O. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0020-2 · Cited by 232
Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands: A review
Houseknecht, K. L., Cole, B. M., & Steele, P. J. (2002) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(01)00117-5 · Cited by 232
Mandard, S., Zandbergen, F., Tan, N. S., Escher, P., Patsouris, D., Koenig, W., Kleemann, R., Bakker, A., Veenman, F., Wahli, W., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403058200 · Cited by 231
Giannopoulou, I., Fernhall, B., Carhart, R., Weinstock, R. S., Baynard, T., Figueroa, A., & Kanaley, J. A. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.033 · Cited by 231
The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality
Davenport, D. L., Xenos, E. S., Hosokawa, P., Radford, J., Henderson, W. G., & Endean, E. D. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.08.052 · Cited by 231
The diversity of sex steroid action: regulation of metabolism by estrogen signaling
Faulds, M. H., Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0044 · Cited by 230
Qatanani, M., Szwergold, N. R., Greaves, D. R., Ahima, R. S., & Lazar, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37273 · Cited by 230
Self-citationAdiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease
Matsuzawa, Y. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.003 · Cited by 229
Metadata
- Authors
- Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A.
- Affiliations
- University of Pennsylvania Health System (US)
- University of Pennsylvania (US)
- Corresponding author
- Lazar, Mitchell A.
- Venue
- Nature
- Published
- 2001-01
- Volume
- 409
- Issue
- 6818
- Pages
- 307-312
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1675830194
- Cited by
- 4,755
- References
- 37
- Citations by year
- 2026: 59 · 2025: 77 · 2024: 108 · 2023: 128 · 2022: 152 · 2021: 147 · 2020: 140 · 2019: 160 · 2018: 137 · 2017: 187 · 2016: 175 · 2015: 197 · 2014: 239 · 2013: 243 · 2012: 217
- FWCI
- 184.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- resistin, obesity, type 2 diabetes, insulin resistance, adipocytes, adipokines, rosiglitazone, glucose tolerance, insulin-stimulated glucose uptake, diet-induced obesity, genetic obesity
- MeSH terms
- Rosiglitazone, Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 19, Cloning, Molecular, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diet, DNA, Female, Gene Expression Regulation, Hormones, Hormones, Ectopic, Humans, Hypoglycemic Agents, Insulin Antagonists, Insulin Resistance, Male, Mice, Inbred C57BL, Molecular Sequence Data, Neutralization Tests, Obesity, Proteins, Thiazoles, Signal Transduction, 3T3 Cells, Adipocytes, Glucose Intolerance, Nerve Growth Factor, Intercellular Signaling Peptides and Proteins, Thiazolidinediones, Mice, Resistin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.